|Bid||22.38 x 1200|
|Ask||22.43 x 800|
|Day's Range||22.15 - 22.53|
|52 Week Range||5.69 - 22.53|
|Beta (5Y Monthly)||0.19|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 04, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||23.00|
BALA CYNWYD, PA / ACCESSWIRE / May 10, 2021 / Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Soliton ("Soliton" or the "Company") (NASDAQ:SOLY) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the agreement to be acquired by Allergan Aesthetics, an AbbVie company (NYSE - ABBV). Under the terms of the agreement, Soliton shareholders will receive only $22.
WILMINGTON, Del., May 10, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Soliton, Inc. (“Soliton”) (NASDAQ GS: SOLY) regarding possible breaches of fiduciary duties and other violations of law related to Soliton’s agreement to be acquired by AbbVie Inc. (“AbbVie”) (NYSE: ABBV). Under the terms of the agreement, Soliton’s shareholders will receive $22.60 in cash per share. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-soliton-inc. You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or firstname.lastname@example.org. Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide. Attorney advertising. Prior results do not guarantee a similar outcome. CONTACT: Rigrodsky Law, P.A.Seth D. RigrodskyGina M. Serra(888) 969-4242 (Toll Free)(302) 295-5310Fax: (302) email@example.com https://rl-legal.com
Ademi LLP is investigating Soliton (NASDAQ: SOLY) for possible breaches of fiduciary duty and other violations of law in its transaction with AbbVie.